Related Experiment Video
Updated: May 8, 2025

09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
6.3K
Materials Advances in Devices for Heart Disease Interventions
Gagan K Jalandhra1, Lauryn Srethbhakdi1, James Davies1
1Graduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Advanced Materials (Deerfield Beach, Fla.)
|April 17, 2025
Summary
Advanced materials are crucial for innovative heart disease interventions, from monitoring and symptom management to tissue repair. Materials science drives progress in cardiovascular treatments and patient outcomes.
Area of Science:
- Biomaterials Science and Engineering
- Cardiovascular Medicine
- Regenerative Medicine
Background:
- Heart disease is a broad category including coronary artery disease, arrhythmias, and heart muscle conditions.
- Current interventions focus on monitoring, symptom management, and tissue repair, each with unique material needs.
Purpose of the Study:
- To review material properties and requirements essential for advanced heart disease intervention strategies.
- To highlight recent progress in materials research driving innovation in cardiovascular treatments.
Main Methods:
- Exploration of material properties supporting cardiac monitoring sensor technology.
- Analysis of materials for managing cardiac output, electrophysiology, and hemodynamics.
- Review of materials for repairing damaged cardiac tissue, including myocardium and heart valves.
Main Results:
- Specific material properties are critical for the optimal function of diverse cardiovascular intervention technologies.
- Advances in materials science are directly enabling new diagnostic, therapeutic, and regenerative approaches for heart disease.
Conclusions:
- Materials science and engineering are pivotal in developing next-generation heart disease interventions.
- Continued research into advanced materials will significantly improve treatment efficacy and patient outcomes in cardiovascular care.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
302
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
302

